Sema4, a Mount Sinai spinout, launches with a focus on genomics
Mount Sinai Health System’s new spinout company, Sema4, will rely on genomic and clinical data to better diagnose, treat and prevent diseases.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
